Vascular calcification
- 1 July 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Nephrology and Hypertension
- Vol. 22 (4), 405-412
- https://doi.org/10.1097/mnh.0b013e328362155b
Abstract
This review presents new evidence related to molecular mechanisms involved in the process of cardiovascular calcification, as well as to discuss new biomarkers and novel therapeutic strategies related to vascular calcification in chronic kidney disease (CKD) patients. microRNAs have emerged as potential players in the genesis of osteo-chondrogenic transformation, depending on the stimulus and the localization of vascular calcification. The disturbances of the fibroblast growth factor-23 (FGF23)/alpha-Klotho (Klotho) axis observed in CKD appear to play an important role in CKD-associated vascular calcification. Numerous studies have identified circulating biomarkers potentially responsible for vascular calcification and have evaluated their link with this process. The respective role of these biomarkers is not yet elucidated. Beyond phosphate binders, modulation of calcium-sensing receptor and vitamin K supplementation come into sight as new potential strategies to prevent cardiovascular calcification. A better understanding of the molecular mechanisms which are responsible for cardiovascular calcification have led to a better detection and more adequate follow-up of this pathologic process, as well as the identification of novel therapeutic targets. Whether these new insights will lead to improved care and better survival of CKD patients with cardiovascular calcification remains to be demonstrated.Keywords
This publication has 62 references indexed in Scilit:
- Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expressionKidney International, 2013
- Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cellsNephrology Dialysis Transplantation, 2012
- Bone Morphogenetic Protein‐2 Decreases MicroRNA‐30b and MicroRNA‐30c to Promote Vascular Smooth Muscle Cell CalcificationJournal of the American Heart Association, 2012
- miR-133a Regulates Vitamin K 2,3-Epoxide Reductase Complex Subunit 1 (VKORC1), a Key Protein in the Vitamin K CycleMolecular Medicine, 2012
- Inorganic Phosphate Accelerates the Migration of Vascular Smooth Muscle Cells: Evidence for the Involvement of miR-223PLOS ONE, 2012
- The role of FGF23 in CKD—with or without KlothoNature Reviews Nephrology, 2012
- miRNA-141 is a novel regulator of BMP-2–mediated calcification in aortic stenosisThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Differentiation of multipotent vascular stem cells contributes to vascular diseasesNature Communications, 2012
- FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stagesOsteoporosis International, 2011
- miR-143 and miR-145Circulation: Cardiovascular Genetics, 2011